US EditionPublished • loading... • Updated
Vertex Pharmaceuticals (NASDAQ:VRTX) Announces Earnings Results, Misses Estimates By $0.34 EPS
Summary by watchlistnews.com
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Vertex Pharmaceuticals (NASDAQ:VRTX) Announces Earnings Results, Misses Estimates By $0.34 EPS
Vertex Pharmaceuticals (NASDAQ:VRTX – Get Free Report) announced its earnings results on Monday. The pharmaceutical company reported $4.22 EPS for the quarter, missing the consensus estimate of $4.56 by ($0.34), Zacks reports. Vertex Pharmaceuticals had a return on equity of 23.91% and a net margin of 31.86%. Vertex Pharmaceuticals Trading Up 0.1% NASDAQ:VRTX traded up […]
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
